Search
for
Sort by
Research 601–630 of 1000+
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- How not to detect prostate cancer
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Faculty Opinions recommendation of Screening for prostate cancer.
- Hedgehog signalling in skin development and cancer
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Epithelial-Stromal Interactions in Basal Cell Cancer: The PDGF System
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Nanoparticle systems reduce systemic toxicity in cancer treatment
- The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
- New Methods of Endocrine Management of Prostatic Cancer
- Anti-androgen hormonal therapy for cancer and other diseases
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Hair disorders in patients with cancer
- RANK as a therapeutic target in cancer
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Alopecia With Endocrine Therapies in Patients With Cancer
- Potential of nano-phytochemicals in cervical cancer therapy
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
- Glycyrrhetinic Acid Functionalized Nanoparticles for Drug Delivery to Liver Cancer
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Prevention and treatment of experimental prostate cancer in lobund-wistar rats. I. Effects of estradiol, dihydrotestosterone, and castration
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- Epidemiology and Risk Factors for Testicular Cancer: A Systematic Review
- Runx1 Role in Epithelial and Cancer Cell Proliferation Implicates Lipid Metabolism and Scd1 and Soat1 Activity
- Chemical and green synthesis of nanoparticles and their efficacy on cancer cells
- Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin